entertainment -WSS

entertainment

author：comprehensive 2025-09-29 01:08:17 - browse：9387

What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a singular regulator?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We explain the debate over Vertex Pharmaceuticals’ novel pain drug, whose success in clinical trials comes with a sizable caveat. We also talk about the latest news in the life sciences, including an epitaph for Aduhelm and the retirement of an FDA icon.

For more on what we cover, here’s the news on Vertex; here’s more on Aduhelm; here’s the exit interview with Janet Woodcock; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： JPM 2024: Verve Therapeutics looks to mainstream genome editing

WSS

More tobacco lobbyists active in statehouses

After traumatic brain injury, life support decisions can use more time

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Orangutan used medicinal plant to treat wound, first time ever seen

How I ended up pumping milk in a bathroom stall at JPM 2024

Getting Alzheimer's drug Leqembi to patients can be a challenge

Wikipedia

entertainment

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

H5N1 bird flu virus started spreading in cows in Texas in December

23andMe had bad news about my health. I wish a person had delivered it

H5N1 bird flu virus started spreading in cows in Texas in December

Affirmative action in medical school literally saved lives

Q&A: Jennifer Adair on making gene therapy available globally

Walensky prepares to leave CDC — and Congress — behind

DeSantis can now import cheaper drugs. But will Biden get credit?

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD podcast: live from JPM 2024

hotspot

How I ended up pumping milk in a bathroom stall at JPM 2024

New England Journal of Medicine addresses racist history, slavery

More tobacco lobbyists active in statehouses

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Idaho abortion case may prompt more restrictions in other states

knowledge

focus

leisure time

leisure time